Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
New omicron subvariants are rising in U.S., and FDA panel gives its backing to Novavax vaccine
01:17pm, Wednesday, 08'th Jun 2022
The BA.4 and BA.5 subvariants of the highly transmissible omicron variant of the coronavirus that causes COVID-19 are spreading rapidly, according to data from the Centers for Disease Control and Prev
Why Is Novavax (NVAX) Down 11.7% Since Last Earnings Report?
12:48pm, Wednesday, 08'th Jun 2022
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock?
Novavax CEO: There's a global market for our vaccine
11:19am, Wednesday, 08'th Jun 2022
Novavax CEO Stanley Erck joins Yahoo Finance Live Senior Health Reporter Anjalee Khemlani to discuss expectations for the upcoming FDA vote regarding the Novavax COVID-19 vaccine, stock data, and the
NVAX Stock Price Predictions: Where Will Novavax Go From Here?
11:06am, Wednesday, 08'th Jun 2022
NVAX stock price predictions are in the spotlight after its vaccine got an unanimous recommendation from the FDA's advisory panel yesterday. The post NVAX Stock Price Predictions: Where Will Novavax G
Why Novavax Stock Is Jumping Today
10:12am, Wednesday, 08'th Jun 2022
An FDA advisory committee voted to recommend authorization for Novavax's COVID-19 vaccine.
What's Next For Novavax Stock As COVID Vaccine Clears Key Hurdle In US
08:11am, Wednesday, 08'th Jun 2022
After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ: NVAX) can now heave a sigh of relief. Adcom Unanimously Back Novavax: FDA's
Novavax shares jump as FDA panel backs COVID vaccine
07:27am, Wednesday, 08'th Jun 2022
Shares of Novavax Inc surged nearly 20% on Wednesday after advisers to the Food and Drug Administration overwhelmingly backed the use of its COVID-19 vaccine, bringing the shot a step closer to a U.S.
FDA Advisors Back Novavax's Covid Shot, Clearing Way for Authorization
06:22am, Wednesday, 08'th Jun 2022
The Food and Drug Administration's vaccines advisory panel backed Novavax 's long-delayed Covid-19 vaccine, saying the benefits outweighed the risks.
Novavax Covid-19 vaccine recommended for US approval by FDA advisory panel
04:46am, Wednesday, 08'th Jun 2022
Novavax, Inc. (NASDAQ:NVAX) said its Covid-19 vaccine has been recommended for approval by the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. The
FDA Panel Endorses Novavax, a Fourth COVID Vaccine
06:11pm, Tuesday, 07'th Jun 2022
The FDA itself still needs to authorize the two-dose series.
Novavax COVID vaccine gets backing from FDA advisory panel
05:06pm, Tuesday, 07'th Jun 2022
Yahoo Finance's Anjalee Khemlani joins the Live show to detail Novavax's FDA approval for its two-dose COVID vaccine for adults.
FDA Advisory Panel Endorses Novavax—1st Protein-Based Covid Vaccine
04:20pm, Tuesday, 07'th Jun 2022
The FDA typically follows the panel's recommendations for approval, which would make the shot the fourth FDA-authorized Covid-19 vaccine for adults.
FDA advisory committee recommends Novavax's COVID-19 vaccine for use
03:45pm, Tuesday, 07'th Jun 2022
American adults who haven't yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
What's Going On With Novavax Stock Today?
03:39pm, Tuesday, 07'th Jun 2022
Novavax Inc (NASDAQ: NVAX) shares have been halted since the pre-market session as the U.S. Food and Drug Administration holds a meeting to determine the fate of the company's COVID-19 vaccine. A
